Skip to main content

previous disabled Page of 5
and
  1. Article

    Open Access

    Long-term survivals of immune checkpoint inhibitors as neoadjuvant and adjuvant therapy in dMMR/MSI-H colorectal and gastric cancers

    The long-term survival benefit of immune checkpoint inhibitors (ICIs) in neoadjuvant and adjuvant settings is unclear for colorectal cancers (CRC) and gastric cancers (GC) with deficiency of mismatch repair (d...

    Zhenghang Wang, Siyuan Cheng, Yanhong Yao, Shengde Liu in Cancer Immunology, Immunotherapy (2024)

  2. Article

    Open Access

    Exploring ALK fusion in colorectal cancer: a case series and comprehensive analysis

    Anaplastic lymphoma kinase (ALK) fusion-positive colorectal cancer (CRC) is a rare and chemotherapy-refractory subtype that lacks established and effective treatment strategies. Additionally, the efficacy and ...

    Zi-**g Li, William Pat Fong, Dong-Sheng Zhang, Hui-Yan Luo in npj Precision Oncology (2024)

  3. Article

    Open Access

    Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes

    The synergistic effects of combining arsenic compounds with imatinib against chronic myeloid leukemia (CML) have been established using in vitro data. We conducted a clinical trial to compare the efficacy of t...

    Jie Tian, Yong-** Song, Gao-Chong Zhang in Journal of Cancer Research and Clinical On… (2024)

  4. Article

    Open Access

    XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial

    Fluoropyrimidine-based combination chemotherapy plus targeted therapy is the standard initial treatment for unresectable metastatic colorectal cancer (mCRC), but the prognosis remains poor. This phase 3 trial ...

    Qiu-Zhong Pan, **g-**g Zhao, Liang Liu in Signal Transduction and Targeted Therapy (2024)

  5. Article

    Open Access

    Correction: c-Myc-driven glycolysis polarizes functional regulatory B cells that trigger pathogenic inflammatory responses

    Xu-Yan Wang, Yuan Wei, Bo Hu, Yuan Liao in Signal Transduction and Targeted Therapy (2024)

  6. Article

    Open Access

    Alpha5 nicotine acetylcholine receptor subunit promotes intrahepatic cholangiocarcinoma metastasis

    Neurotransmitter-initiated signaling pathway were reported to play an important role in regulating the malignant phenotype of tumor cells. Cancer cells could exhibit a “neural addiction” property and build up ...

    Yan Fu, Keyu Shen, Hao Wang, Shun Wang in Signal Transduction and Targeted Therapy (2024)

  7. Article

    Open Access

    The role of dynamic, static, and delayed total-body PET imaging in the detection and differential diagnosis of oncological lesions

    Commercialized total-body PET scanners can provide high-quality images due to its ultra-high sensitivity. We compared the dynamic, regular static, and delayed 18F-fluorodeoxyglucose (FDG) scans to detect lesio...

    Ya** Wu, Fangfang Fu, Nan Meng, Zhenguo Wang, **aochen Li, Yan Bai in Cancer Imaging (2024)

  8. Article

    Open Access

    Single-cell RNA sequencing of a new transgenic t(8;21) preleukemia mouse model reveals regulatory networks promoting leukemic transformation

    T(8;21)(q22;q22), which generates the AML1-ETO fusion oncoprotein, is a common chromosomal abnormality in acute myeloid leukemia (AML) patients. Despite having favorable prognosis, 40% of patients will relapse...

    Ming Yan, Mengdan Liu, Amanda G. Davis, Samuel A. Stoner, Dong-Er Zhang in Leukemia (2024)

  9. Article

    Open Access

    Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study

    This prospective multicenter phase II study evaluated the clinical efficacy of neoadjuvant nivolumab-exclusive (N) and nivolumab–chemotherapy (N/C) combinations based on PD-L1 expression. Eligible patients exh...

    Si-Yang Liu, Song Dong, Xue-Ning Yang in Signal Transduction and Targeted Therapy (2023)

  10. Article

    Open Access

    Risk prediction of second primary malignancies after gynecological malignant neoplasms resection with and without radiation therapy: a population-based surveillance, epidemiology, and end results (SEER) analysis

    The association between post-resection radiotherapy for primary gynecological malignant neoplasms (GMNs) and the development of secondary primary malignancies (SPMs) remains a subject of debate. This study rep...

    **g Wang, Chan Zhang, Yaoxian **ang in Journal of Cancer Research and Clinical On… (2023)

  11. Article

    Open Access

    Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors

    With the continuous in-depth study of the interaction mechanism between viruses and hosts, the virus has become a promising tool in cancer treatment. In fact, many oncolytic viruses with selectivity and effect...

    Bopei Cui, Lifang Song, Qian Wang, Kelei Li in Signal Transduction and Targeted Therapy (2023)

  12. Article

    Open Access

    Expression of tumor-associated macrophages and PD-L1 in patients with hepatocellular carcinoma and construction of a prognostic model

    Hepatocellular carcinoma (HCC) is an inflammation-associated tumor involved in immune tolerance and evasion in the immune microenvironment. Immunotherapy can enhance the immune response of the body, break immu...

    Panpan kong, Huan Yang, Qing Tong in Journal of Cancer Research and Clinical On… (2023)

  13. No Access

    Article

    Does the last 20 years paradigm of clinical research using volatile organic compounds to non-invasively diagnose cancer need to change? Challenges and future direction

    Volatile organic compounds (VOCs) have shown great potential as novel biomarkers for cancer detection; however, comprehensive quantitative analysis is lacking. In this study, we performed a bibliometric analys...

    Shi-Yan Tan, Qiong Ma, Fang Li, Hua Jiang in Journal of Cancer Research and Clinical On… (2023)

  14. Article

    Open Access

    Cryo-EM structure of the nucleocapsid-like assembly of respiratory syncytial virus

    Respiratory syncytial virus (RSV) is a nonsegmented, negative strand RNA virus that has caused severe lower respiratory tract infections of high mortality rates in infants and the elderly, yet no effective vac...

    Yan Wang, Chong Zhang, Yongbo Luo, **aobin Ling in Signal Transduction and Targeted Therapy (2023)

  15. Article

    Open Access

    High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA

    Normal high-density lipoprotein (nHDL) can induce angiogenesis in healthy individuals. However, HDL from patients with coronary artery disease undergoes various modifications, becomes dysfunctional (dHDL), and...

    Zhi-Wei Mo, Yue-Ming Peng, Yi-**n Zhang, Yan Li in Signal Transduction and Targeted Therapy (2023)

  16. No Access

    Article

    Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients

    The impacts of macrovascular invasion (MVI) or extrahepatic spread (EHS) on the efficacy and safety of immune checkpoint inhibitors (ICIs) among hepatocellular carcinoma (HCC) patients remain unclear. Thus, we...

    Cheng-Long Han, Bao-Wen Tian, Lun-Jie Yan, Zi-Niu Ding in Cancer Immunology, Immunotherapy (2023)

  17. No Access

    Article

    Adjuvant radiotherapy in patients with node-positive prostate cancer after radical prostatectomy

    Our study was to determine whether immediate androgen deprivation therapy (ADT) plus radiotherapy (RT) extends survival in men with node-positive prostate cancer (PCa) after radical prostatectomy (RP) compared...

    Huan Chen, Min Qu, Haoqing Shi in Journal of Cancer Research and Clinical On… (2023)

  18. Article

    Open Access

    Efficacy and safety of different PD-1 inhibitors in combination with lenvatinib in the treatment of unresectable primary liver cancer: a multicentre retrospective study

    Immune checkpoint inhibitors (ICIs) are safe and efficacious treatments for advanced primary liver cancer (PLC). The efficacy of different ICIs in the treatment of liver cancer remains unclear. The purpose of ...

    Qi-mei Li, Qing-can Sun, Yan Jian, **g-zhe He, Hong-bo Zhu in Discover Oncology (2023)

  19. No Access

    Article

    Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis

    Immune checkpoint inhibitors (ICIs) have been explored as first-line treatment in various types of previously untreatable malignancies, while limited evidence is available on the management of hepatitis B viru...

    Zi-Niu Ding, Guang-**ao Meng, Jun-Shuai Xue in Journal of Cancer Research and Clinical On… (2023)

  20. No Access

    Article

    Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades

    Tumor vaccines for hepatocellular carcinoma (HCC) is an area of intense interest. Tremendous clinical trials have been conducted globally, but the efficacy and security of tumor vaccines are elusive. The aim o...

    Cheng-Long Han, Yu-Chuan Yan, Lun-Jie Yan in Journal of Cancer Research and Clinical On… (2023)

previous disabled Page of 5